ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
+5.98%Margins
Gross margin
100.0%
EBITDA margin
-800.2%
EBIT margin
-912.4%
Net margin
-850.1%
FCF margin
-1142.6%
1182.1%
Return on equity
-58.1%
Return on assets
-555.1%
Return on invested capital
0.06x
Asset turnover
-$158.2M
Cash from operations
$1.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026